QSAR Evaluation of the Ch'an Su and Related Bufadienolides against the Colchicine-Resistant Primary Liver Carcinoma Cell Line PLC/PRF/5
Journal of Medicinal Chemistry2002Vol. 45(25), pp. 5440–5447
Citations Over Time
Yoshiaki Kamano, Ayano Yamashita, Toshihiko Nogawa, Hiroshi Morita, Koichi Takeya, Hideji Itokawa, Toshiaki Segawa, Ayako Yukita, Kyoko Saito, Mariko Katsuyama, George R. Pettit
Abstract
QSAR analysis has been used to identify the essential structural requirements for increasing the inhibitory activities of selected bufadienolides from the Chinese drug Ch'an Su (and other sources) against the primary liver carcinoma cell line PLC/PRF/5 (PLC) and the derived colchicine-resistant line (COL). The variable substituent domain of the proposed pharmacophore of the bufadienolides was investigated using a Comparative Molecular Field Analysis (CoMFA) approach. A model with considerable predictive ability was obtained. In addition, the CoMFA results agreed well with the pharmacophore bufadienolide model for the parent PLC line proposed earlier.
Related Papers
- → Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions(2013)13 cited
- → Photoreaction of 2-morpholinoacrylonitrile with substituted 1-acetonaphthones. Part II(2001)8 cited
- → 3D-QSAR and pharmacophore model study on aryl diphenolic azoles as estrogen receptor-β ligands(2013)
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)